Titan Biotech Ltd.
BSE: 524717 | Sector: Health care |
NSE: N.A. | ISIN Code: INE150C01011 |
BSE 00:00 | 12 Aug | 233.95 |
-4.40 (-1.85%) |
OPEN
241.50 |
HIGH
244.75 |
LOW
231.05 |
NSE 05:30 | 01 Jan | Titan Biotech Ltd |
OPEN | 241.50 |
PREVIOUS CLOSE | 238.35 |
VOLUME | 10625 |
52-Week high | 388.50 |
52-Week low | 205.40 |
P/E | 9.66 |
Mkt Cap.(Rs cr) | 193 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 913.40 | -6.60 | -0.72 | 15585.98 |
Dr Reddy's Labs | 4262.25 | 5.10 | 0.12 | 14405.20 |
Cipla | 1027.35 | -11.05 | -1.06 | 13091.79 |
Lupin | 682.60 | -7.30 | -1.06 | 11771.67 |
Aurobindo Pharma | 593.30 | 17.85 | 3.10 | 11287.14 |
Divi's Lab. | 3728.20 | -219.60 | -5.56 | 8879.82 |
Alkem Lab | 2959.90 | -14.50 | -0.49 | 8829.81 |
Zydus Lifesci. | 386.90 | 5.15 | 1.35 | 7981.90 |
Glenmark Pharma. | 389.00 | 0.10 | 0.03 | 7567.93 |
Torrent Pharma. | 1539.20 | 3.95 | 0.26 | 6742.32 |
Apollo Hospitals | 4309.85 | -124.40 | -2.81 | 6098.30 |
Ipca Labs. | 928.00 | -87.50 | -8.62 | 5399.36 |
Alembic Pharma | 652.55 | 2.10 | 0.32 | 5051.44 |
Abbott India | 18761.95 | -180.00 | -0.95 | 4919.27 |
Laurus Labs | 565.75 | 0.70 | 0.12 | 4707.04 |
Gland Pharma | 2363.30 | 15.65 | 0.67 | 4400.71 |
Granules India | 310.45 | 3.95 | 1.29 | 3238.44 |
Glaxosmi. Pharma | 1441.95 | -0.35 | -0.02 | 3217.51 |
Ajanta Pharma | 1276.30 | 5.50 | 0.43 | 3140.64 |
Sanofi India | 6382.90 | -24.20 | -0.38 | 2956.60 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices